110 related articles for article (PubMed ID: 23636824)
1. Insight into structural diversity of influenza virus haemagglutinin.
Cho KJ; Lee JH; Hong KW; Kim SH; Park Y; Lee JY; Kang S; Kim S; Yang JH; Kim EK; Seok JH; Unzai S; Park SY; Saelens X; Kim CJ; Lee JY; Kang C; Oh HB; Chung MS; Kim KH
J Gen Virol; 2013 Aug; 94(Pt 8):1712-1722. PubMed ID: 23636824
[TBL] [Abstract][Full Text] [Related]
2. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
3. Antigen distortion allows influenza virus to escape neutralization.
Fleury D; Wharton SA; Skehel JJ; Knossow M; Bizebard T
Nat Struct Biol; 1998 Feb; 5(2):119-23. PubMed ID: 9461077
[TBL] [Abstract][Full Text] [Related]
4. Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form.
Seok JH; Kim J; Lee DB; Cho KJ; Lee JH; Bae G; Chung MS; Kim KH
Sci Rep; 2017 Aug; 7(1):7540. PubMed ID: 28790432
[TBL] [Abstract][Full Text] [Related]
5. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
[TBL] [Abstract][Full Text] [Related]
6. Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.
Wang W; Sun X; Li Y; Su J; Ling Z; Zhang T; Wang F; Zhang H; Chen H; Ding J; Sun B
Nat Commun; 2016 Dec; 7():13577. PubMed ID: 27910950
[TBL] [Abstract][Full Text] [Related]
7. An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.
Vanlandschoot P; Beirnaert E; Barrère B; Calder L; Millar B; Wharton S; Jou WM; Fiers W
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1781-91. PubMed ID: 9680143
[TBL] [Abstract][Full Text] [Related]
8. Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin.
Cho KJ; Hong KW; Kim SH; Seok JH; Kim S; Lee JH; Saelens X; Kim KH
PLoS One; 2014; 9(2):e89803. PubMed ID: 24587046
[TBL] [Abstract][Full Text] [Related]
9. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen.
Cabral TM; Baig A; Berhane Y; Schmidt L; Hole K; Leith M; Kobasa D; Corbett CR
J Virol Methods; 2014 Jan; 195():54-62. PubMed ID: 24060631
[TBL] [Abstract][Full Text] [Related]
10. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
11. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
12. A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.
Wu NC; Wilson IA
J Mol Biol; 2017 Aug; 429(17):2694-2709. PubMed ID: 28648617
[TBL] [Abstract][Full Text] [Related]
13. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
14. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
16. Identification of a linear epitope on the haemagglutinin protein of pandemic A/H1N1 2009 influenza virus using monoclonal antibodies.
Chen Y; Zhang J; Qiao C; Wang J; Yang H; Chen H
Arch Virol; 2014 Jun; 159(6):1413-9. PubMed ID: 24385157
[TBL] [Abstract][Full Text] [Related]
17. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.
Xu R; Wilson IA
J Virol; 2011 May; 85(10):5172-82. PubMed ID: 21367895
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
Cabral TM; Berhane Y; Schmidt L; Tracz DM; Hole K; Leith M; Corbett CR
J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
